Apheresis only partially controls raised low density lipoprotein cholesterol levels in patients with homozygous familial hypercholesterolemia, who usually respond poorly to lipid-lowering drugs.
A D Marais +5 more
doaj +1 more source
The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19 [PDF]
B.R. Jaeger +3 more
openalex +1 more source
Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss
Fibrinogen/LDL apheresis has been proven to be effective in treatment of sudden sensorineural hearing loss (SSNH). This study is aimed to investigate if reduction of fibrinogen and serum LDL is also effective in patients with SSNH non-responding toward ...
M. Canis, F. Heigl, M. Suckfuell
semanticscholar +1 more source
Egy ritka, veleszületett neurodegeneratív betegség: a cerebrotendinosus xanthomatosis laboratóriumi diagnosztikája [PDF]
Cerebrotendinous xanthomatosis is a rare neurodegenerative disease characterized by the accumulation of cholesterol and cholestanol in the brain and the tendons caused by mutations of the gene encoding sterol 27-hydroxylase (CYP27A1), which is involved ...
Balogh István +10 more
core +1 more source
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
Background. The aim of the study was to investigate the changes in plasma lipids and lipoproteins and the cardiovascular events after selective LDL apheresis. Methods and Results.
G. Kolovou +9 more
semanticscholar +1 more source
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1
We measured oxidized phospholipids (OxPL), lipoprotein (a) [Lp(a)], and lipoprotein-associated phospholipase A2 (Lp-PLA2) pre- and postapheresis in 18 patients with familial hypercholesterolemia (FH) and with low(∼10 mg/dl; range 10–11 mg/dl ...
Kiyohito Arai +8 more
doaj +1 more source
P6242Impact of evolocumab, a PCSK9 inhibitor, withdrawing from regular ldl-apheresis therapy in patients with heterozygous familial hypercholesterolemia [PDF]
Masa‐aki Kawashiri +6 more
openalex +1 more source
Short-term Effect of LDL-Apheresis on Lipid Profile of Patients with Nephrotic and Non-Nephrotic Hyperlipidemia: A Comparative Study [PDF]
Abduzhappar Gaipov +10 more
openalex +1 more source
Pancytopenia with severe thrombocytopenia in a patient treated with twice‐weekly LDL‐apheresis by polyacrylate adsorption from whole blood [PDF]
Rainer Nowack, Günther Wiedemann
openalex +1 more source

